AUM $5.2MER 0.47%NAV $34.94Holdings 73Inception Aug 2022
Price Chart
Key Statistics
Previous Close
$33.96Day Range
$34.39$34.88
52-Week Range
$21.78$36.08
Avg Volume
2.3KDividend Yield
1.00%Expense Ratio
0.47%AUM
$5.2MShares Outstanding
154.0KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 69.65% |
| Ireland | 5.26% |
| Canada | 4.53% |
| Netherlands | 4.03% |
| United Kingdom | 3.86% |
| Sweden | 2.26% |
| South Korea | 1.93% |
| Denmark | 1.87% |
| Switzerland | 1.26% |
| China | 1.17% |
| Australia | 1.11% |
| Japan | 1.05% |
| France | 0.72% |
| Israel | 0.55% |
| Other | 0.41% |
| Italy | 0.34% |
Fund Information
- Issuer
- iShares
- Category
- Healthcare
- Types
- GrowthTechnology
- Inception Date
- Aug 24, 2022
- Exchange
- NYSE_ARCA
- Description
- The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.
Similar ETFs
The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund issued by iShares that launched on Aug 24, 2022. It currently manages $5.2M in assets under management. The fund charges an expense ratio of 0.47%. The fund holds 73 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 43.3% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ALKS | ALKERMES | 5.33% | 6,446 | $280K |
| 2 | AXSM | AXSOME THERAPEUTICS INC | 5.02% | 1,138 | $263K |
| 3 | NBIX | NEUROCRINE BIOSCIENCES INC | 4.62% | 1,448 | $242K |
| 4 | XENE | XENON PHARMACEUTICALS INC | 4.47% | 4,419 | $234K |
| 5 | ARWR | ARROWHEAD PHARMACEUTICALS INC | 4.43% | 3,088 | $232K |
| 6 | ARGX | ARGENX SE ADR | 4.13% | 257 | $216K |
| 7 | PTCT | PTC THERAPEUTICS INC | 3.96% | 2,938 | $208K |
| 8 | CNTA | CENTESSA PHARMACEUTICALS AMERICAN | 3.94% | 5,186 | $206K |
| 9 | BIIB | BIOGEN INC | 3.76% | 1,004 | $197K |
| 10 | CPRX | CATALYST PHARMACEUTICALS INC | 3.61% | 6,048 | $189K |
| 11 | SRRK | SCHOLAR ROCK HOLDING CORP | 3.52% | 4,075 | $185K |
| 12 | ACAD | ACADIA PHARMACEUTICALS INC | 3.45% | 8,328 | $181K |
| 13 | DNTH | DIANTHUS THERAPEUTICS INC | 3.21% | 1,998 | $168K |
| 14 | EWTX | EDGEWISE THERAPEUTICS INC | 3.01% | 4,232 | $158K |
| 15 | PRAX | PRAXIS PRECISION MEDICINES INC | 3.00% | 594 | $157K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +2.71% | |
| 1W | -0.66% | |
| 1M | -3.67% | |
| 3M | +10.42% | |
| 6M | +6.72% | |
| YTD | +9.15% | |
| 1Y | +48.33% | |
| 3Y | +33.74% | |
| 5Y | +41.22% |
Moving Averages
20-Day MA
$34.71
Above 20-Day MA50-Day MA
$34.67
Above 50-Day MA200-Day MA
$31.06
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$36.08
Current Price
$34.88
52-Week Low
$21.78
$21.78$36.08
Current Yield
1.00%
Annual Dividend
$0.4355
Frequency
1x/year
Last Ex-Date
Dec 16, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 16, 2025 | $0.3198 | Dec 19, 2025 |
| Dec 17, 2024 | $0.1011 | Dec 20, 2024 |
| Dec 20, 2023 | $0.0063 | Dec 27, 2023 |
| Jun 7, 2023 | $0.0082 | Jun 13, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | IBRN | Healthcare(174 ETFs) | Growth(409 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.47% | 0.60% | 0.66% |
| AUM | $5.2M | $875.8M | $3.01B |
| Dividend Yield | 1.00% | 3.42% | 5.84% |
| Avg Volume | 2.3K | 270.2K | 219.5K |
| Holdings | 73 | 89 | 79 |
| Performance | |||
| 1-Month Return | -3.15% | +2.02% | +0.15% |
| 6-Month Return | +7.03% | +3.84% | +4.77% |
| YTD Return | +7.35% | +3.23% | +6.48% |
| 1-Year Return | +45.70% | +23.91% | +19.09% |
Compare with Another ETF
Search for an ETF to compare with IBRN:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.